Search PubMed⌕ Search

PubMed · 15257367

[The cardiologist should suspect more thyroid dysfunction!].

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Angelo V A de Paola, Cláudio Cirenza, Rui M B Maciel. 2004-07-12. [The cardiologist should suspect more thyroid dysfunction!].. https://doi.org/10.1590/s0066-782x2004000600002

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Spectral turbulence analysis of the signal-averaged electrocardiogram of the atrial activation as predictor of recurrence of idiopathic and persistent atrial fibrillation.

The frequency domain analysis of the P-wave signal-averaged ECG (P-SAECG) is able to identify patients at risk for lone atrial fibrillation (AF) after cardioversion to sinus rhythm. The terminal portion of the P-wave of right precordial leads on 12-lead ECG is associated with electrical abnormalities in the atria. The aim of this study was to assess the spectral turbulence analysis (STA) of the P-SAECG as a predictor of recurrence of idiopathic AF. STA was performed in 41 patients with 2 or more symptomatic episodes of idiopathic and persistent AF after successful electrical cardioversion and drug-free state (Group A), and in 25 control individuals during sinus rhythm (Group B), matched by age, gender, and P-wave duration. The orientation of the terminal portion (positive or negative) of the Z-lead was assessed as representing right precordial leads potentials. After 6 months follow-up, Group A was divided into two groups according to recurrence: G-A1--at least one recurrence (21 patients), and G-A2--no recurrence (20 patients). Fragmented electrical activity (FEA) was observed in 19 patients of G-A1 and in 2 of G-A2 (odds ratio = 85.5; p<<0.001). STA showed 90.5% sensitivity and 90.0% specificity for early recurrence of AF. After 12 months, no patients of G-A2 and 15 of G-A1 developed >3 episodes of persistent AF, being FEA observed in 13 (odds ratio = 14.6, p = 0.002). No episodes of AF were observed in Group B. Average time for recurrence of FEA positive patients (4.3 +/- 0.7 months) was significantly shorter than of G-A2 (7.4+/-0.7 months), and log-rank analysis revealed significant difference of event-free rate over time (p = 0.004). In a logistic regression model FEA, use of amiodarone and a positive terminal portion of the Z-lead of the P-SAECG were independent predictors of recurrence of idiopathic and persistent AF.

Amiodarone↗

Intravenous amiodarone treatment in horses with chronic atrial fibrillation.

Six horses without underlying cardiac disease were presented because of atrial fibrillation of between 5 and 12 months duration. These horses received an intravenous amiodarone treatment of 5mg/kg/h for 1 h followed by 0.83mg/kg/h for 23h and subsequently 1.9mg/kg/h for 30h. During treatment, clinical signs were monitored and a surface ECG and an intra-atrial electrogram were recorded. Infusion was discontinued when sinus rhythm or side effects occurred. Four horses successfully cardioverted, of which one showed symptoms of hind limb weakness and weight shifting. Two horses did not cardiovert and showed similar side effects. In all horses, side effects disappeared within 6h after termination of treatment. Cardiac side effects, such as pro-arrhythmia, were not seen in any of the horses. Total bilirubin slightly increased in three horses and normalised within four days. It was concluded that amiodarone has the potential to treat naturally occurring chronic atrial fibrillation in horses, although further research is needed to refine the infusion protocol.

Amiodarone↗

Functional genomics of cardiac ion channel genes.

Ion channels are an ensemble of specialized membrane proteins that act in concert to create and modulate the electrical activity of many excitable cells, including cardiac myocytes. Following completion of the sequencing of various genomes, including that of the human, the complete repertoire of ion channel genes has been elucidated for different species. How transcripts issued from this gene collection are expressed and modulated in relation to variable physiological and pathological situations is the subject of functional or physiological genomics. Specialized microarrays (IonChips) comprising probes for the ensemble of ion channel and regulatory genes were developed as an alternative to whole-genome DNA chips. Physiological genomics of cardiac ion channel genes is a growing field that, in combination with genetics, should markedly increase our comprehension of the molecular mechanisms leading to arrhythmias.

Amiodarone↗